ORIC

Oric Pharmaceuticals, Inc.

10.99 USD
-0.03 (-0.27%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Oric Pharmaceuticals, Inc. stock is up 7.64% since 30 days ago. The next earnings date is Mar 14, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 3 February’s closed higher than January. In the last 4 Unusual Options Trades, there were 4 CALLs.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
12 Jan 18:24 16 Feb, 2024 7.50 CALL 250 2015
12 Jan 18:24 16 Feb, 2024 7.50 CALL 250 2015
17 Jan 15:57 16 Feb, 2024 7.50 CALL 1000 1515
24 Jan 15:43 15 Mar, 2024 12.50 CALL 244 0

About Oric Pharmaceuticals, Inc.

ORIC Pharmaceuticals, Inc. discovers and develops therapies for treatment of cancers. Its product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment regimens. The company was incorporated in 2014 and is headquartered in South San Francisco, California.